Lu et al. [129] also discovered through proteomics that iminostilbene reduces HIF-1α expression and STAT3 phosphorylation by targeting PKM2, mitigating inflammation and myocardial damage after MI. The gene discussed is HIF1A; the disease is myocardial infarction.